Physical Activity and Rate of Visual Field Loss

A study to be published in the journal, “Ophthalmology” looked at the association between level of physical  activity  in patients with  glaucoma and rate of  visual field loss.[1] This study is what would be called a longitudinal observational study which essentially...

Trabeculotomy or Goniotomy – Just Defer It

Why Defer Trabeculotomy or Goniotomy Recently there has been a large increase in the number of cataract and glaucoma surgeons who are performing a type of minimally invasive glaucoma surgery that goes by various names, all of which have the term “goniotomy” or...

Does the CyPass Glaucoma Implant Damage the Eye?

What is the CyPass Stent? The CyPass is a small tube-shaped device that has for the last few years been implanted in patients with glaucoma. This was done at the time of cataract surgery in order to shunt fluid from the front of the eye into a space where it can then...

PolyActiva Commences Clinical Trial of Biodegradable Ocular Implant for Glaucoma

Clinical Trial Begins For PolyActiva Biodegradable Glaucoma Implant. PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently received USD$12million in venture capital to fund its Phase 1 Clinical Trial which will evaluate the safety and tolerability of its PA5108 ocular implant designed to biodegrade after the treatment period.

MicroInvasive Glaucoma Surgery (MIGS) Where To Next?

Iqbal Ike K. Ahmed, MD, FRCSC, asks surgeons to comment on what excites them about the future of minimally invasive glaucoma surgery (MIGS). Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; and David Richardson, MD, discuss MIGS devices in the pipeline and explain how these procedures improve the quality of life for both patients and physicians.

Ab Interno Canaloplasty (ABiC™) In The Spotlight

Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.

Pin It on Pinterest